Further, as a result of grading analysis for HOXB2 in breast cancer using Oncomine, HOXB2 expression was found to be significantly lower in grade 3 tumors in 7 out of 14 existing microarray studies10. The gene discussed is HOXB2; the disease is breast carcinoma.